equipment
chinese machinary      chinese equipment      
Main page | News | Guestbook | Contact us
Русская версия

Products:
Mini-factories
Transport
Equipment
Instruments
Food products
Building materials
Leisure and garden inventory
Medicine and public health
Gas and gas equipment
Oil equipment
Chinese Silk
Underwear, T-shirts
Various production line by Customers order
Silver coins
SERVICES
Safety
ABOUT US

Contact us
Tel: +86 13903612274
Email: mega@asia-business.biz

News from China
Buses bringing construction workers back
26th February 2020

 The builder of several landmarks in the Lingang area chartered buses on Tuesday morning to pick up migrant workers and return them to their jobs. 

 
Nine buses from the Lingang headquarters of China Construction Eighth Engineering Division Corp will take back 157 workers from Jiangsu, Anhui and Jiangxi provinces for the construction of the second and third stages of Harbor City Plaza, Lingang Science and Technology City and other projects.
 
Workers will be picked up at designated stops in nine cities which are not in key affected areas. All the buses will be half full and there will be support personnel on board.
 
The details of every worker will be noted with health declaration forms filled out. 
 
After they arriving in Shanghai, they will have their temperatures measured before getting off the bus and be in quarantine for 14 days.
 
During the quarantine period, they will be paid and the company will provide free accommodation.
 
Despite the novel coronavirus pneumonia outbreak, also known as COVID-19, 971 companies in Lingang have resumed work. By the start of this week, over 40,000 people had gone back to work there, with precautionary measures ensuring safety, said Wu Xiaohua, deputy director of the Lingang Special Area Administrative Committee.
 
Almost every enterprise with an annual output of 100 million yuan and above in Lingang had resumed operation, Wu said.
 
Construction of buildings in 19 new projects has also resumed, Wu added.
 
Source: Shanghai Daily, February 26, 2020
Jiading District is springing back to work!
25th February 2020

 Instead of waiting for winter to pass, it is better to take the initiative to welcome the arrival of spring.

 
With more and more enterprises resuming operations in Jiading, frontline workers have done a good job in epidemic prevention and control on the one hand, and made full preparations for ensuring production on the other, to let development become a strong support in dealing with the epidemic.
 
As of 9pm on February 16, 2,027 enterprises have resumed operations in Jiading, accounting for nearly 30 percent of the total and involving 72,000 workers.
 
Among enterprises with an annual business income of 20 million yuan (US$2.86 million) and above, 841 have resumed operations, accounting for 68.3 percent of the total.
 
Although the enterprises in Jiading resumed operations one after another, the lack of human resources is a key issue which tests their ability in overall planning and allocation, as well as efficiency in management and technological innovation.
 
Aptiv Electrical Centers (Shanghai) Co was one of the earliest in Anting Town to resume production. It quickly increased its production capacity by 45 percent with just 25 percent of human resources.
 
In Shanghai Fengge Nonwoven Co in Xuhang Town, the factory director becomes an operator and the sales manager works as a warehouse keeper.
 
Affected by the epidemic, no more than a quarter of frontline personnel went back to work on the first day when the company resumed operations. However, the company dispatched sales and administrative personnel to the forefront to maintain the full load operation of a production line.
 
An antibacterial non-woven mask developed by the company has obtained qualification and will be put into production soon. It is reported that the mask has a long-term antibacterial effect and can be used for a long time.
 
Shanghai Zhongxi Pharmaceutical Co in Waigang Town accelerated production of hydroxychloroquine sulfate tablets since a clinical test to treat novel coronavirus pneumonia with hydroxychloroquine was launched by the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and Shanghai Pharmaceutical Group.
 
Another medicine produced by the company — chloroquine phosphate tablet — has been found to be one of the three drugs that inhibit the virus at cellular level, and the inhibition effect is significant in the late stage of clinical trials.
 
Hence, the company resumed the production of the tablet immediately and delivered the first batch on February 14. At present, nearly 40 percent of the company’s employees have returned to work.
 
Source: Shanghai Daily,February 25, 2020
China reports sufficient vegetable supplies but higher prices
21st February 2020

 China's vegetable supplies were generally sufficient despite an uptick in prices, according to data from the Ministry of Agriculture and Rural Affairs.

 
China currently has more than 84 million mu (5.6 million hectares) of vegetables grown in the fields. Data from the ministry's 1,000 vegetable monitoring centers showed that supplies increased 2.7 percent year on year in the recent two months.
 
However, there has been an uptick in prices as the Spring Festival holiday and the ongoing COVID-19 epidemic pushed up logistics costs and caused people to stock up on vegetables.
 
The average wholesale price of 28 types of vegetables monitored by the ministry surged 23.7 percent year on year in January. The increase in vegetable prices pushed the country's consumer price index up 0.45 percentage points, data from the National Bureau of Statistics showed.
 
The ministry vowed greater efforts to ensure vegetable supplies especially in Wuhan, the epicenter of the outbreak, and other hard-hit areas, as well as get farmers fully prepared for the spring plowing season to lay a solid foundation for the year's harvest.
Source: Shanghai Daily, February 21, 2020
Scientists refute theories suggesting COVID-19 has no natural origin
20th February 2020

 Health experts from multiple countries have rejected claims that COVID-19 does not have a natural origin, and condemned related conspiracy theories.

 
"We are public health scientists who have closely followed the emergence of 2019 novel coronavirus disease (COVID-19) and are deeply concerned about its impact on global health and wellbeing," 27 experts from around the world said in an online statement published on Wednesday by The Lancet, a world-renowned general medical journal.
 
Speaking highly of the "remarkable effort" of Chinese scientists and health professionals in identifying the pathogen, reducing its impact and sharing information, they noted that "the rapid, open, and transparent sharing of data on this outbreak is now being threatened by rumors and misinformation around its origins."
 
Scientists from multiple countries have published and analysed genomes of the causative agent, and "overwhelmingly conclude that this coronavirus originated in wildlife, as have so many other emerging pathogens," said the statement.
 
"This is further supported by a letter from the presidents of the US National Academies of Science, Engineering, and Medicine and by the scientific communities they represent," added the statement.
 
"We stand together to strongly condemn conspiracy theories suggesting that COVID-19 does not have a natural origin," they said, stressing that "conspiracy theories do nothing but create fear, rumors, and prejudice that jeopardise our global collaboration in the fight against this virus."
 
The scientists also voiced support for the call from World Health Organization Director-General Tedros Adhanom Ghebreyesus "to promote scientific evidence and unity over misinformation and conjecture."
 
Source: Shanghai Daily, February 20, 2020

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208